ATC code C10

From Wikipedia, the free encyclopedia
Jump to: navigation, search
ATC codes
C Cardiovascular system
C01 Cardiac therapy
C02 Antihypertensives
C03 Diuretics
C04 Peripheral vasodilators
C05 Vasoprotectives
C07 Beta blocking agents
C08 Calcium channel blockers
C09 Agents acting on the renin-angiotensin system
C10 Lipid modifying agents
(Hover over links to see titles.)

ATC code C10 Lipid modifying agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C10 is part of the anatomical group C Cardiovascular system.[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QC10...[2]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

Contents

[edit] C10A Lipid modifying agents, plain

[edit] C10AA HMG CoA reductase inhibitors

C10AA01 Simvastatin
C10AA02 Lovastatin
C10AA03 Pravastatin
C10AA04 Fluvastatin
C10AA05 Atorvastatin
C10AA06 Cerivastatin
C10AA07 Rosuvastatin
C10AA08 Pitavastatin

[edit] C10AB Fibrates

C10AB01 Clofibrate
C10AB02 Bezafibrate
C10AB03 Aluminium clofibrate
C10AB04 Gemfibrozil
C10AB05 Fenofibrate
C10AB06 Simfibrate
C10AB07 Ronifibrate
C10AB08 Ciprofibrate
C10AB09 Etofibrate
C10AB10 Clofibride
C10AB11 Choline fenofibrate

[edit] C10AC Bile acid sequestrants

C10AC01 Colestyramine
C10AC02 Colestipol
C10AC03 Colextran
C10AC04 Colesevelam

[edit] C10AD Nicotinic acid and derivatives

C10AD01 Niceritrol
C10AD02 Nicotinic acid
C10AD03 Nicofuranose
C10AD04 Aluminium nicotinate
C10AD05 Nicotinyl alcohol (pyridylcarbinol)
C10AD06 Acipimox
C10AD52 Nicotinic acid, combinations

[edit] C10AX Other lipid modifying agents

C10AX01 Dextrothyroxine
C10AX02 Probucol
C10AX03 Tiadenol
C10AX05 Meglutol
C10AX06 Omega-3-triglycerides
C10AX07 Magnesium pyridoxal 5-phosphate glutamate
C10AX08 Policosanol
C10AX09 Ezetimibe
C10AX10 Alipogene tiparvovec
C10AX11 Mipomersen

[edit] C10B Lipid modifying agents, combinations

[edit] C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents

C10BA01 Lovastatin and nicotinic acid
C10BA02 Simvastatin and ezetimibe
C10BA03 Pravastatin and fenofibrate

[edit] C10BX HMG CoA reductase inhibitors, other combinations

C10BX01 Simvastatin and acetylsalicylic acid
C10BX02 Pravastatin and acetylsalicylic acid
C10BX03 Atorvastatin and amlodipine
C10BX04 Simvastatin, acetylsalicylic acid and ramipril

[edit] References

  1. ^ "ATC/DDD Index 2012". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/. 
  2. ^ "ATCvet Index 2012". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/. 
GI tract
Liver
Niacin and derivatives (HDL and LDL)
Blood vessels
Combinations
Other

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m(A16/C10),i(k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
Retrieved from "http://en.wikipedia.org/w/index.php?title=ATC_code_C10&oldid=469525605"
Personal tools
Namespaces
Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Languages